icometrix raises over 2M to boost the use of its clinical SaaS product MSmetrix
Leuven, Belgium: 13 January 2016 - icometrix develops and markets MSmetrix, which is SaaS software to support radiologists and neurologists in the follow-up of Multiple Sclerosis patients.
The company raised over € 2 million additional capital. Investors include Capricorn ICT Arkiv, Annie Vereecken (Biover II), former Cartagenia (now part of Agilent Technologies) CEO Herman Verrelst, and current shareholders, such as the Universities of Antwerp and Leuven and the Antwerp University Hospital. The proceeds will be invested to reach icometrix' ambitious targets for 2016: increasing the use of MSmetrix worldwide, capacitating its branch office in the US, addressing new disease domains, and expanding their business in clinical trials and research studies. Other plans for 2016 include growing the icometrix sales force and development team and moving into a new office.
Next > LindaCare signs collaboration agreement with The University Hospitals Leuven (UZ Leuven)
Previous > Watching the Tokyo Olympics with beer in the new PEF bottle launch of Mitsui compound